Literature DB >> 17443633

Randomisation to protect against selection bias in healthcare trials.

R Kunz1, G Vist, A D Oxman.   

Abstract

BACKGROUND: Randomised trials use the play of chance to assign participants to comparison groups. The unpredictability of the process, if not subverted, should prevent systematic differences between comparison groups (selection bias), provided that a sufficient number of people are randomised.
OBJECTIVES: To assess the effects of randomisation and concealment of allocation on the results of healthcare trials. SEARCH STRATEGY: We searched the Cochrane Methodology Register, MEDLINE, SciSearch, reference lists up to August 2000 and used personal communication. SELECTION CRITERIA: Cohorts of trials, systematic reviews or meta-analyses of healthcare interventions that compared outcomes or prognostic factors for one of the following comparisons: randomised versus non-randomised trials, randomised trials with adequately versus inadequately concealed allocation, or high versus low quality trials where selection bias could not be separated from other sources of bias. DATA COLLECTION AND ANALYSIS: One of us went through all of the citations in the Cochrane Methodology Register and accumulated reference lists. Studies that appeared to meet the inclusion criteria were retrieved and assessed independently by two of the reviewers. The methodological quality of included studies was appraised and information extracted by one of us and checked by a second. Tabular summaries of the results were prepared for each comparison and the results across studies were assessed qualitatively to identify common trends or discrepancies. MAIN
RESULTS: We identified 32 studies including over 3000 trials. Twenty-two studies compared randomised versus non-randomised trials, three compared adequately versus inadequately concealed allocation, and nine compared high versus low quality trials (some studies included more than one comparison). Five studies were of high methodological quality. In 15 of the 22 studies that compared randomised and non-randomised trials of the same intervention, important differences were found in the estimates of effect. Some of these differences were due to a poorer prognosis in the control groups in the non-randomised trials. The results of the other seven studies that compared randomised and non-randomised trials across different interventions are less clear. Comparisons of adequately and inadequately concealed allocation in randomised trials of the same intervention provided high quality evidence that concealment can be crucial in achieving similar treatment groups and, therefore, unbiased estimates of treatment effects. Studies with inadequate concealment tended to overestimate treatment effects. Comparisons of high and low quality trials of the same intervention have found important differences in estimates of effect, but it is not possible to determine the extent to which these differences can be attributed to randomisation or concealment of allocation. Omitting comparisons between randomised trials and non-randomised trials using historical controls did not substantially alter the results or conclusions of our review. AUTHORS'
CONCLUSIONS: On average, non-randomised trials and randomised trials with inadequate concealment of allocation tend to result in larger estimates of effect than randomised trials with adequately concealed allocation. However, it is not generally possible to predict the magnitude, or even the direction, of possible selection biases and consequent distortions of treatment effects.

Entities:  

Mesh:

Year:  2007        PMID: 17443633     DOI: 10.1002/14651858.MR000012.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  63 in total

Review 1.  Assessing the quality of research.

Authors:  Paul Glasziou; Jan P Vandenbroucke; Iain Chalmers
Journal:  BMJ       Date:  2004-01-03

Review 2.  Artificial and bioartificial support systems for liver failure.

Authors:  J P Liu; L L Gluud; B Als-Nielsen; C Gluud
Journal:  Cochrane Database Syst Rev       Date:  2004

Review 3.  Robotic Versus Laparoscopic Hysterectomy for Benign Disease: A Systematic Review and Meta-Analysis of Randomized Trials.

Authors:  Benjamin B Albright; Tilman Witte; Alena N Tofte; Jeremy Chou; Jonathan D Black; Vrunda B Desai; Elisabeth A Erekson
Journal:  J Minim Invasive Gynecol       Date:  2015-08-10       Impact factor: 4.137

4.  CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.

Authors:  David Moher; Sally Hopewell; Kenneth F Schulz; Victor Montori; Peter C Gøtzsche; P J Devereaux; Diana Elbourne; Matthias Egger; Douglas G Altman
Journal:  BMJ       Date:  2010-03-23

Review 5.  Clinical research methodology I: introduction to randomized trials.

Authors:  Lillian S Kao; Jon E Tyson; Martin L Blakely; Kevin P Lally
Journal:  J Am Coll Surg       Date:  2008-02       Impact factor: 6.113

Review 6.  Strategies for postmarketing surveillance of drugs and devices in patients with ESRD undergoing dialysis.

Authors:  Moshe Vardi; Robert W Yeh; Charles A Herzog; Wolfgang C Winkelmayer; Soko Setoguchi; David M Charytan
Journal:  Clin J Am Soc Nephrol       Date:  2013-08-22       Impact factor: 8.237

7.  What's new in trial design: propensity scores, equivalence, and non-inferiority.

Authors:  Paul S Myles
Journal:  J Extra Corpor Technol       Date:  2009-12

8.  EAES recommendations on methodology of innovation management in endoscopic surgery.

Authors:  Edmund A M Neugebauer; Monika Becker; Gerhard F Buess; Alfred Cuschieri; Hans-Peter Dauben; Abe Fingerhut; Karl H Fuchs; Brigitte Habermalz; Leonid Lantsberg; Mario Morino; Stella Reiter-Theil; Gabriela Soskuty; Wolfgang Wayand; Thilo Welsch
Journal:  Surg Endosc       Date:  2010-01-07       Impact factor: 4.584

9.  Evidence-based medicine in psychopharmacotherapy: possibilities, problems and limitations.

Authors:  Hans-Jürgen Möller; Wolfgang Maier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-02       Impact factor: 5.270

Review 10.  Is evidence sufficient for evidence-based medicine?

Authors:  Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-11       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.